Condition
Prolonged First Stage of Labor
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 90/100
Termination Rate
50.0%
2 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (1)
P 4 (1)
Trial Status
Completed2
Terminated2
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT01937234Phase 4CompletedPrimary
Use of an Antiemetic to Shorten the Length of Labor in Nulliparous Women
NCT01982851Not ApplicableTerminated
Effects of Analgesic Techniques on Duration of Labor for Induction Patients
NCT01982838Not ApplicableTerminated
Effects of Analgesic Techniques on Duration of Spontaneously Laboring Patients
NCT01639027Phase 2CompletedPrimary
Drotaverine to Shorten the Length of Labor
Showing all 4 trials